1. Overexpressed Receptors and Proteins in Lung Cancer
   Bapi Gorain et al, 2019, Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer CrossRef
2. Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight
   Lourdes Cortes-Dericks et al, 2022, Cancers CrossRef
3. Anlotinib exerts anti‐cancer efficiency on lung cancer stem cells in vitro and in vivo through reducing NF‐κB activity
   Zhuohong Li et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
4. A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer
   Buse Cevatemre et al, 2018, Pharmacological Research CrossRef
5. A Systematic Analysis Identifies Key Regulators Involved in Cell Proliferation and Potential Drugs for the Treatment of Human Lung Adenocarcinoma
   Kai Wang et al, 2021, Frontiers in Oncology CrossRef
6. Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancer
   Tareq Saleh et al, 2016, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
7. Redox-Regulation in Cancer Stem Cells
   Uwe Lendeckel et al, 2022, Biomedicines CrossRef
8. Promise of cancer stem cell vaccine
   Li Zhou et al, 2015, Human Vaccines & Immunotherapeutics CrossRef
9. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell
   Zhidong Wang et al, 2016, Tumor Biology CrossRef
10. Combined effects of octreotide and cisplatin on the proliferation of side population cells from anaplastic thyroid cancer cell lines
    Zhilan Li et al, 2018, Oncology Letters CrossRef
11. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
    Weiqiang Zhou et al, 2019, Current Medicinal Chemistry CrossRef
12. Hypericin affects cancer side populations via competitive inhibition of BCRP
    Jana Vargová et al, 2018, Biomedicine & Pharmacotherapy CrossRef
13. Cancer Stem Cells and Autophagy: Present Knowledge and Future Perspectives
    Bakiye Goker Bagca et al, 2018, Autophagy in Health and Disease CrossRef
14. Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC (Review)
    Lige Qiu et al, 2017, Oncology Letters CrossRef
15. Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro
    WEN-JING WANG et al, 2016, Oncology Reports CrossRef
16. Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
    Bartosz Mateusz Gąsiorkiewicz et al, 2021, Investigational New Drugs CrossRef
17. Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer
    Somayeh Hashemi Sheikhshabani et al, 2024, Cancer Reports CrossRef
18. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation
    Juan Sebastian Yakisich et al, 2017, Journal of Cellular Physiology CrossRef